1,961 participants with BMI of 30+ (or 27+ with at least one weight-related condition) received either semaglutide 2.4 mg or placebo weekly for 68 weeks, alongside lifestyle intervention
DahlqvistSRosengrenAGudbjrnsdottirSPivodicAWedelHKosiborodMet alRisk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study
Patients whose primary complaint is physical performance and recovery rather than energy or cognition
5 Related Stories Study links GLP-1 treatment to fewer alcohol drinking days GLP-1 weight-loss drugs may also reduce binge eating Semaglutide dose may matter more than weight loss for heart health GLP-1RAs have emerged as potential alternatives for treating addiction-related behaviors
Estos compuestos se diferencian en sus propiedades farmacodinmicas y farmacocinticas, sin embargo, son similares en su eficacia hipoglicemiante, y todos se administran por va oral48,49
Parkinsons research trials in numbers: three key facts The 2024 report, published in the , revealed there were Journal of Parkinsons Disease 136 active clinical trials registered on ClinicalTrials.gov as of January 31 this year, compared to 139 trials the previous year